๐ The impact of the SARS-CoV-2 outbreak on the safety and availability of blood transfusions in Italy.
Coronaviruses are enveloped single-stranded RNA viruses belonging to the family of Coronaviridae. While initial research focused on their ability to cause enzootic infections, infections which have emerged in the past two decades demonstrate their ability to cross the species barrier and infect humans [1,2]. The ensuing epidemics have included Severe Acute Respiratory Syndrome (SARS) in 2002 and the more recent Middle East Respiratory Syndrome (MERS) in 2012, and have resulted in severe disease burden, mortality and economic disruption [3]. A novel flu-like coronavirus, emerging towards the end of 2019 and subsequently named SARS-CoV-2, has been associated with an epidemic initially focused in Wuhan, China.
keywords
author
๐ค Franchini, Massimo
๐ค Farrugia, Albert
๐ค Velati, Claudio
๐ค Zanetti, Alessandro
๐ค Romano, Luisa
๐ค Grazzini, Giuliano
๐ค Lopez, Nadia
๐ค Pati, Ilaria
๐ค Marano, Giuseppe
๐ค Pupella, Simonetta
๐ค Maria Liumbruno, Giancarlo
year
โฐ 2020
journal
๐ Vox Sang
issn
๐
volume
number
page
citedbycount
0
download
๐ [BibTeX]